Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of TOWA PHARMACEUTICAL CO., LTD.. A complete text table follows the diagram.
Domestic volume grew, but U.S. product weakness, European costs and Sansei pressure left operating profit flat; derivatives lifted net profit.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Domestic | 1 | 104.9B | 80.4% of reported total |
| Overseas segment | 1 | 25.6B | 19.6% of reported total |
| Revenues From External Customers | 2 | 130.5B | Reported six-month total · ¥130.5B |
| Operating profit | 3 | 10.4B | 8.0% operating margin |
| Operating costs & expenses | 3 | 120.0B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 12.0B | Reported pretax result |
| Net non-operating income | 3 | 1.5B | Arithmetic bridge to reported pretax profit |
| Net profit attributable to owners | 5 | 8.2B | Reported parent-company result |
| Tax, attribution & other | 5 | 3.7B | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Domestic | Revenues From External Customers | 104.9B |
| Overseas segment | Revenues From External Customers | 25.6B |
| Revenues From External Customers | Operating profit | 10.4B |
| Revenues From External Customers | Operating costs & expenses | 120.0B |
| Operating profit | Profit before tax | 10.4B |
| Net non-operating income | Profit before tax | 1.5B |
| Profit before tax | Net profit attributable to owners | 8.2B |
| Profit before tax | Tax, attribution & other | 3.7B |